Cited by 1,378Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment ApproachesInfective Endocarditis Diagnosis and Management

Aortic Stenosis in the Elderly

Open access
Osnabrugge, Ruben L.J., Mylotte, Darren, Head, Stuart J., Van Mieghem, Nicolas M., Nkomo, Vuyisile T., LeReun, Corinne M., Bogers, Ad J.J.C., Piazza, Nicolo +1 more·2013·Journal of the American College of Cardiology

Abstract

Objectives The purpose of this study was to evaluate the prevalence of aortic stenosis (AS) in the elderly and to estimate the current and future number of candidates for transcatheter aortic valve replacement (TAVR).Background Severe AS is a major cause of morbidity and mortality in the elderly. A proportion of these patients is at high or prohibitive risk for surgical aortic valve replacement, and is now considered for TAVR.Methods A systematic search was conducted in multiple databases, and prevalence rates of patients (>75 years) were pooled. A model was based on a second systematic literature search of studies on decision making in AS. Monte Carlo simulations were performed to estimate the number of TAVR candidates in 19 European countries and North America.Results Data from 7 studies (n = 9,723 subjects) were used. The pooled prevalence of all AS in the elderly was 12.4% (95% confidence interval [CI]: 6.6% to 18.2%), and the prevalence of severe AS was 3.4% (95% CI: 1.1% to 5.7%). Among elderly patients with severe AS, 75.6% (95% CI: 65.8% to 85.4%) were symptomatic, and 40.5% (95% CI: 35.8% to 45.1%) of these patients were not treated surgically. Of those, 40.3% (95% CI: 33.8% to 46.7%) received TAVR. Of the high-risk patients, 5.2% were TAVR candidates. Projections showed that there are approximately 189,836 (95% CI: 80,281 to 347,372) TAVR candidates in the European countries and 102,558 (95% CI: 43,612 to 187,002) in North America. Annually, there are 17,712 (95% CI: 7,590 to 32,691) new TAVR candidates in the European countries and 9,189 (95% CI: 3,898 to 16,682) in North America.Conclusions With a pooled prevalence of 3.4%, the burden of disease among the elderly due to severe AS is substantial. Under the current indications, approximately 290,000 elderly patients with severe AS are TAVR candidates. Nearly 27,000 patients become eligible for TAVR annually.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jacc.2013.05.015

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The burden of calcific aortic stenosis is expected to rise over the coming decades because of population aging and the absence of a prevention strategy that reduces disease progression.

    “The burden of calcific AS in the community is expected to increase over the next decades owing to population aging and the lack of a prevention strategy aimed at reducing disease progression.”

    From Calcific aortic stenosis (2016) · cites this paper as [16]

    The introductory passage following Conclusions (pp. 1002–12) expects the public-health impact of aortic stenosis to increase as populations age. The Results also projects more elderly patients with symptomatic severe aortic stenosis in 2025 and 2050. Our copy does not identify the absence of a prevention strategy that slows progression as a reason for that increase. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • In developed countries, the number of patients with calcific aortic stenosis older than 70 or 75 years is predicted to increase twofold to threefold over the next 50 years.

    “Estimates based on current prevalence rates and demographic forecasts predict that the number of patients with calcific AS >70 or >75 years of age will increase twofold to threefold over the next 50 years in developed countries15;16;19.”

    From Calcific aortic stenosis (2016) · cites this paper as [16]

    The Results project that symptomatic severe aortic stenosis in people aged 75 or older will rise from 1.0 to 2.1 million in the studied European countries and from 540,000 to 1.4 million in North America by 2050—roughly a twofold to threefold increase. The paper does not give that projection specifically for calcific stenosis, people over 70, or a 50-year period. The indexed Results passage has no page number. (LLM, conf=0.85)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [12]12. Lorz W, Cottier C, Gyr N. The prevalence of aortic stenosis in an elderly population: an echocardiographic study in a small Swiss community. Cardiol Elderly 1993;1:511-5.

Cited by

Sorted by citations

Authors
Osnabrugge, R. L. J., Mylotte, D., Head, S. J., Van Mieghem, N. M., Nkomo, V. T., LeReun, C. M., Bogers, A. J. J. C., Piazza, N., & Kappetein, A. P.
Affiliations
  • Erasmus MC (NL)
  • McGill University Health Centre (CA)
  • Mayo Clinic (US)
Corresponding author
Kappetein, A. Pieter
Venue
Journal of the American College of Cardiology
Publisher
Elsevier BV
Published
2013-09
Volume
62
Issue
11
Pages
1002-1012
ISSN
0735-1097 (ISSN-L)
OpenAlex
W1575075233
Cited by
1,378
References
31
Citations by year
2026: 130 · 2025: 157 · 2024: 156 · 2023: 144 · 2022: 127 · 2021: 116 · 2020: 112 · 2019: 98 · 2018: 91 · 2017: 76 · 2016: 84 · 2015: 45 · 2014: 25 · 2013: 10 · 2012: 1
FWCI
37.19
Type
journal article
Language
en
Open access
Locations
  • Journal of the American College of Cardiology (publishedVersion)
  • PubMed (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • ARAN (University of Galway Research Repository) (Ollscoil na Gaillimhe – University of Galway) (acceptedVersion, cc-by-nc-nd)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • Arrow@dit (Dublin Institute of Technology) (submittedVersion)
  • ARAN (University of Galway Research Repository) (Ollscoil na Gaillimhe – University of Galway) (submittedVersion, cc-by-nc-nd)
  • ARAN (University of Galway Research Repository) (Ollscoil na Gaillimhe – University of Galway) (submittedVersion, cc-by-nc)
  • Research Repository UCD (University College Dublin) (cc-by-nc)
Funders
  • Medtronic
  • Edwards Lifesciences
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Valve Diseases and Treatments
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Aortic Disease and Treatment Approaches
  • Health Sciences › Medicine › Epidemiology › Infective Endocarditis Diagnosis and Management
Keywords
aortic stenosis, older adults, prevalence, transcatheter aortic valve implantation, high-risk surgical patients, surgical aortic valve replacement, disease burden, decision-making, Monte Carlo simulation, North America, symptomatic aortic stenosis, cost-effectiveness, quality of life
MeSH terms
Aged, Aged, 80 and over, Aortic Valve, Aortic Valve Stenosis, Cross-Sectional Studies, Europe, Female, Humans, Male, North America, Risk Factors, Severity of Illness Index, Prevalence, Heart Valve Prosthesis Implantation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review